APA

Schneider C., Oellerich T., Baldauf H., Schwarz S., Thomas D., Flick R., Bohnenberger H., Kaderali L., Stegmann L., Cremer A., Martin M., Lohmeyer J., Michaelis M., Hornung V., Schliemann C., Berdel W. E., Hartmann W., Wardelmann E., Comoglio F., Hansmann M., Yakunin A. F., Geisslinger G., Ströbel P., Ferreirós N., Serve H., Keppler O. T. & Cinatl J. (20170814). SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia. : Nature medicine.

Chicago

Schneider Constanze, Oellerich Thomas, Baldauf Hanna-Mari, Schwarz Sarah-Marie, Thomas Dominique, Flick Robert, Bohnenberger Hanibal, Kaderali Lars, Stegmann Lena, Cremer Anjali, Martin Margarethe, Lohmeyer Julian, Michaelis Martin, Hornung Veit, Schliemann Christoph, Berdel Wolfgang E, Hartmann Wolfgang, Wardelmann Eva, Comoglio Federico, Hansmann Martin-Leo, Yakunin Alexander F, Geisslinger Gerd, Ströbel Philipp, Ferreirós Nerea, Serve Hubert, Keppler Oliver T and Cinatl Jindrich. 20170814. SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia. : Nature medicine.

Harvard

Schneider C., Oellerich T., Baldauf H., Schwarz S., Thomas D., Flick R., Bohnenberger H., Kaderali L., Stegmann L., Cremer A., Martin M., Lohmeyer J., Michaelis M., Hornung V., Schliemann C., Berdel W. E., Hartmann W., Wardelmann E., Comoglio F., Hansmann M., Yakunin A. F., Geisslinger G., Ströbel P., Ferreirós N., Serve H., Keppler O. T. and Cinatl J. (20170814). SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia. : Nature medicine.

MLA

Schneider Constanze, Oellerich Thomas, Baldauf Hanna-Mari, Schwarz Sarah-Marie, Thomas Dominique, Flick Robert, Bohnenberger Hanibal, Kaderali Lars, Stegmann Lena, Cremer Anjali, Martin Margarethe, Lohmeyer Julian, Michaelis Martin, Hornung Veit, Schliemann Christoph, Berdel Wolfgang E, Hartmann Wolfgang, Wardelmann Eva, Comoglio Federico, Hansmann Martin-Leo, Yakunin Alexander F, Geisslinger Gerd, Ströbel Philipp, Ferreirós Nerea, Serve Hubert, Keppler Oliver T and Cinatl Jindrich. SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia. : Nature medicine. 20170814.